Natalia V Lavrova - Epidemiology

Author Information

Natalia V. Lavrova is affiliated with the N. F. Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, located in Moscow, Russia. She has made significant contributions to the field of microbiology and epidemiology, focusing particularly on bacterial enzymes and biofilm disruption.

Research Contributions

Natalia V. Lavrova's research primarily revolves around bacterial enzymes, biofilm disruption, and the pharmacokinetics of antibacterial agents. Her work includes the study of lysostaphin, an antibacterial enzyme, and its modifications to enhance its therapeutic efficacy. Additionally, she has investigated the suppression of biofilm formation by various bacterial species and the production of recombinant proteins with potential medical applications. Her research has practical implications for the treatment of bacterial infections and the development of novel antibacterial therapies.

Aliases

Natalia V. Lavrova is also known by several aliases in scientific literature, including N. V. Lavrova, N. Lavrova, and N V Lavrova.

Publication and Citation Metrics

Metric	Value
Total Citations	250
H-index	10
Number of Papers	51

Publications:

Fusion of Lysostaphin to an Albumin Binding Domain Prolongs Its Half-Life and Bactericidal Activity in the Systemic Circulation

DOI: 10.3390/molecules24162892

Year: 2019

The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin

DOI: 10.3390/molecules24101879

Year: 2019

Urgent natural foci infections transmitted by ticks in Saint-Petersburg

DOI: 10.22625/2072-6732-2018-10-4-104-115

Year: 2018

Staphylococcus simulans recombinant lysostaphin: Production, purification, and determination of antistaphylococcal activity

DOI: 10.1134/S0006297916050072

Year: 2016

Disruption of bacterial biofilms using recombinant dispersin B

DOI: 10.1134/S0026261715040062

Year: 2015

Suppression of Pseudomonas aeruginosa biofilm formation by LecA-binding poly- and oligosaccharides from natural sources

DOI:

Year: 2014

The study of the interaction of (cytosine-5)-DNA methyltransferase SsoII with DNA by acoustic method.

DOI: 10.1039/c0an00545b

Year: 2011

Preparation and characterization of recombinant protein containing immunomimetic peptide of benzo(a)pyrene

DOI: 10.3103/S0891416811020029

Year: 2011

Chimeric Lactase Capable of Spontaneous and Strong Immobilization on Cellulose and Development of a Continuous-Flow System for Lactose Hydrolysis at High Temperatures

DOI: 10.1128/AEM.01517-10

Year: 2010

Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo

DOI: 10.1134/S0026893310060099

Year: 2010

Why is Treatment Regimen Complexity Important in Epidemiology?

What is Reference Management?

What is the Scope of Their Work?

What are the Consequences of Resource Loss?

How are Vector Borne Diseases Transmitted?

What is Carotid Artery Stenosis?

How Can Employers Support Prevention Efforts?

What are the Advantages of Using Insurance Claims Data in Epidemiological Research?

How Does Agricultural Use Affect Human Health?

How Does Epidemiology Contribute to the 0by25 Initiative?

Partnered Content Networks

Relevant Topics